{"id":828487,"date":"2025-03-21T08:36:41","date_gmt":"2025-03-21T12:36:41","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-driven-brands-holdings-inc-nasdaq-drvn-kyverna-therapeutics-inc-nasdaq-kytx-mercury-systems-inc-nasdaq-mrcy-and-rocket-lab-usa-inc-nasdaq-rklb\/"},"modified":"2025-03-21T08:36:41","modified_gmt":"2025-03-21T12:36:41","slug":"notice-to-long-term-shareholders-of-driven-brands-holdings-inc-nasdaq-drvn-kyverna-therapeutics-inc-nasdaq-kytx-mercury-systems-inc-nasdaq-mrcy-and-rocket-lab-usa-inc-nasdaq-rklb","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-driven-brands-holdings-inc-nasdaq-drvn-kyverna-therapeutics-inc-nasdaq-kytx-mercury-systems-inc-nasdaq-mrcy-and-rocket-lab-usa-inc-nasdaq-rklb\/","title":{"rendered":"Notice to Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Kyverna Therapeutics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Rocket Lab USA, Inc. (NASDAQ: RKLB): Grabar Law Office is Investigating Claims on Your Behalf"},"content":{"rendered":"
\n

PHILADELPHIA, March 21, 2025 (GLOBE NEWSWIRE) — <\/p>\n

\n
\n Driven Brands Holdings, Inc. (NASDAQ: DRVN) Class Action Survives Motion to Dismiss:<\/u>
\n <\/strong>\n <\/p>\n

\n A securities fraud class action complaint against <\/strong>
\n Driven Brands Holdings, Inc. (NASDAQ: DRVN) has survived defendants, attempts to dismiss the complaint. <\/strong>Grabar Law Office is now investigating claims on behalf of long-term Driven Brands shareholders.\u00a0The investigation concerns whether certain officers of the company have breached their fiduciary duties they owed to the company.<\/p>\n

\n If you have held Driven Brands (NASDAQ: DRVN) shares continuously since prior to <\/strong>
\n October 27, 2021, you can<\/strong>
\n seek corporate reforms, the return of funds back to the Company, and a court approved incentive award at no cost you<\/strong>. Visit <\/strong>https:\/\/grabarlaw.com\/the-latest\/driven-brands-shareholder-investigation\/<\/strong><\/a> or <\/strong>contact Joshua H. Grabar at\u00a0<\/strong>jgrabar@grabarlaw.com<\/u><\/strong><\/a> or call 267-507-6085 <\/strong>to learn more.<\/strong><\/p>\n

\n WHY:<\/strong> An underlying securities fraud class action complaint alleges that Driven Brands, through certain of its officers and directors, made numerous materially false and misleading statements and omissions pertaining to: (i) Driven Brands\u2019 ability to efficiently and effectively integrate a high volume of acquired businesses, including statements related to the status of integrating its U.S. auto glass businesses; and (ii) the performance and competitive position of Driven Brands\u2019 car wash business segment.<\/p>\n

On February 20, 2025, a Federal Court determined that the allegations in the plaintiff\u2019s underlying securities fraud class action complaint were adequately pleaded to survive defendants attempts to dismiss the complaint.<\/p>\n

\n WHAT TO DO NOW:<\/strong> Current Driven Brands shareholders who have held Driven Brands shares since prior to October 27, 2021, can<\/strong> seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to them whatsoever.<\/strong> If you would like to learn more about this matter at no cost to you<\/strong>, you are encouraged to visit <\/strong>https:\/\/grabarlaw.com\/the-latest\/driven-brands-shareholder-investigation\/<\/strong><\/a>, contact Joshua H. Grabar at\u00a0jgrabar@grabarlaw.com<\/u><\/a> or call 267-507-6085. $DRVN #DrivenBrands<\/p>\n

\n
\n Kyverna Therapeutics, Inc. (NASDAQ: KYTX):<\/u>
\n <\/strong>\n <\/p>\n

Grabar Law Office is investigating claims on behalf of Kyverna Therapeutics, Inc. (NASDAQ: KYTX) shareholders. The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.<\/p>\n

\n If you are a current Kyverna (NASDAQ: KYTX) shareholder who purchased Kyverna shares on or near its February 8, 2024 IPO and still hold shares today, <\/strong>
\n you may be able to <\/strong>
\n seek corporate reforms, the return of money back to the company, and a court approved incentive award at no cost to you whatsoever.<\/strong>
\n Please <\/strong>
\n visit <\/strong>
\n https:\/\/grabarlaw.com\/the-latest\/kyverna-shareholder-investigation\/<\/a>
\n , contact Joshua Grabar at\u00a0<\/strong>
\n
\n jgrabar@grabarlaw.com<\/strong>
\n <\/a>
\n ,<\/strong>
\n or call us at 267-507-6085<\/strong>\n <\/p>\n

\n
\n Why?<\/strong> On February 8, 2024, Kyverna Therapeutics, Inc. (NASDAQ: KYTX) conducted its IPO, offering 14.5 million shares of its common stock to the public at a price of $22 per share for anticipated proceeds of over $296 million. Kyverna granted the Underwriter Defendants a 30-day option to purchase up to an additional 2.175 million shares of its common stock at the Offering Price, less underwriting discounts and commissions.<\/p>\n

An underlying securities fraud class action complaint alleges that the registration statement and prospectus issued in connection with the Company\u2019s IPO misstated and\/or omitted facts concerning the results of the Company\u2019s ongoing evaluation of KYV-101 in clinical trials. The Complaint further alleges that unbeknownst to investors, these representations were materially inaccurate, misleading, and\/or incomplete because they did not disclose adverse data regarding one of Kyverna\u2019s trials, which adverse data was known to the Company at the time of the IPO.<\/p>\n

\n What Can You Do Now?<\/strong>
\n If you purchased Kyverna (NASDAQ: KYTX) on or near its February 8, 2024 IPO and still hold shares today, <\/strong>
\n you are encouraged <\/strong>
\n to visit <\/strong>
\n
\n https:\/\/grabarlaw.com\/the-latest\/kyverna-shareholder-investigation\/<\/strong>
\n <\/a>
\n , contact Joshua Grabar at\u00a0<\/strong>
\n
\n jgrabar@grabarlaw.com<\/strong>
\n <\/a>
\n
\n ,<\/u>
\n <\/strong>
\n or call 267-507-6085. You may be able to <\/strong>
\n seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. $KYTX #Kyverna<\/strong>\n <\/p>\n

\n
\n Mercury Systems, Inc. (NASDAQ: MRCY) Class Action Survives Motion to Dismiss:<\/u>
\n <\/strong>\n <\/p>\n

\n A securities fraud class action complaint against <\/strong>
\n Mercury Systems, Inc. (NASDAQ: MRCY) has survived defendants\u2019 attempts to dismiss the complaint. <\/strong>\n <\/p>\n

Grabar Law Office is now investigating claims on behalf of long-term Mercury Systems shareholders. The investigation concerns whether certain officers and directors of Mercury Systems have breached their fiduciary duties owed to the company.<\/p>\n

\n Current Mercury Systems (NASDAQ: MRCY) shareholders who have held shares since prior to <\/strong>
\n February 3, 2021<\/strong>
\n , <\/strong>
\n can <\/strong>
\n seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award, at no cost to them whatsoever.<\/strong>
\n To learn more or join<\/strong>
\n click here:<\/strong>
\n
\n https:\/\/grabarlaw.com\/the-latest\/mercury-systems-shareholder-investigation\/<\/strong>
\n <\/a>
\n .<\/strong>\n <\/p>\n

\n WHY<\/strong>
\n :<\/strong>
\n A recently filed securities fraud class action complaint has now partially survived defendants\u2019 attempts to dismiss that complaint.<\/strong> The underlying complaint alleges that Mercury Systems, through certain of its officers and directors, used acquisitions and improper revenue recognition practices to mask its inability to grow organically. The complaint further alleges that Defendants repeatedly misled investors to believe that their growth was organic by misrepresenting several elements of Mercury\u2019s business, including by hiding that Mercury had switched from \u201cpoint-in-time\u201d to \u201clong-term contracts\u201d in order to improperly boost reported revenues and that several of Mercury\u2019s projects were in significant distress, including projects related to Mercury\u2019s acquisition of Physical Optics Corporation. Finally, the Complaint alleges Mercury also lied to investors about its strategic growth initiative, 1MPACT, which was designed to improve profit margins but unbeknownst to investors was used to disguise regular expenses as restructuring costs, enabling Mercury to claim that recurring expenses were one-time costs.<\/p>\n

\n On February 20, 2025, a Federal Court determined that certain key allegations in the plaintiff\u2019s underlying securities fraud class action complaint were adequately pleaded to survive defendants attempts to dismiss the complaint. <\/strong>\n <\/p>\n

\n WHAT YOU CAN DO NOW: <\/strong>
\n If you have held Mercury Systems shares since prior to <\/strong>
\n February 3, 2021<\/strong>, and<\/strong> would like to learn more about this matter, you are encouraged to visit <\/strong>https:\/\/grabarlaw.com\/the-latest\/mercury-systems-shareholder-investigation\/<\/strong><\/a>, contact Joshua H. Grabar at\u00a0jgrabar@grabarlaw.com<\/a>, or call us at 267-507-6085. $MRCY #MercurySystems<\/p>\n

\n
\n Rocket Lab USA, Inc. (NASDAQ: RKLB)<\/u>
\n <\/strong>\n <\/p>\n

Grabar Law Office is investigating claims on behalf of shareholders of Rocket Lab USA, Inc. (NASDAQ: RKLB). The investigation concerns whether certain officers and directors of Rocket Lab breached the fiduciary duties they owed to the company.<\/p>\n

\n If you are a current Rocket Lab (NASDAQ: RKLB) shareholder who purchased or acquired Rocket Lab shares prior to November 12, 2024, and still hold shares today, <\/strong>
\n you can <\/strong>
\n seek corporate reforms, the return of money back to the company, and a court approved incentive award at no cost to you whatsoever.<\/strong>
\n Please <\/strong>
\n
\n https:\/\/grabarlaw.com\/the-latest\/rklb-shareholder-investigation\/<\/strong>
\n <\/a>
\n , <\/strong>
\n contact Joshua Grabar at\u00a0<\/strong>
\n
\n jgrabar@grabarlaw.com<\/strong>
\n <\/a>
\n ,<\/strong>
\n or call us at 267-507-6085<\/strong>\n <\/p>\n

\n Why?<\/strong>\u00a0\u00a0 According to an underlying securities fraud class action complaint, it is alleged that Rocket Lab (NASDAQ: RKLB), through certain of its officers, made materially false and\/or misleading statements, as well as failed to disclose material adverse facts about the Company\u2019s business, operations, and prospects. Specifically, the Complaint alleges Defendants failed to disclose to investors that: (1) the Company\u2019s plans for three barge landing tests were significantly delayed; (2) a critical potable water problem was not scheduled to be fixed until January 2026, which delayed preparation of the launch pad; (3) as a result of the foregoing, there was a substantial risk that Rocket Lab\u2019s Neutron rocket would not launch in mid-2025; (4) Neutron\u2019s only contract was made at a discount with an unreliable partner; and (5) that, as a result of the foregoing, Defendants\u2019 positive statements about the Company\u2019s business, operations, and prospects were materially misleading and\/or lacked a reasonable basis.<\/p>\n

\n What You Can Do Now:<\/strong>
\n If you purchased Rocket Lab shares prior to November 12, 2024, and still hold shares today, <\/strong>
\n you are encouraged to visit <\/strong>
\n
\n https:\/\/grabarlaw.com\/the-latest\/rklb-shareholder-investigation\/<\/strong>
\n <\/a>
\n , contact Joshua Grabar at\u00a0<\/strong>
\n
\n jgrabar@grabarlaw.com<\/strong>
\n <\/a>
\n ,<\/strong>
\n or call 267-507-6085. You may be able to seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.<\/strong> $RKLB #RocketLab<\/p>\n

\n Attorney Advertising Disclaimer<\/a>\n <\/p>\n

Contact:
Joshua H. Grabar, Esq.
Grabar Law Office
One Liberty Place
1650 Market Street, Suite 3600
Philadelphia, PA 19103
Tel: \u00a0267-507-6085
Email: jgrabar@grabarlaw.com<\/a><\/p>\n

A photo accompanying this announcement is available at https:\/\/www.globenewswire.com\/NewsRoom\/AttachmentNg\/095e26b5-da04-4598-8413-8cb47e60a6a7<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

PHILADELPHIA, March 21, 2025 (GLOBE NEWSWIRE) — Driven Brands Holdings, Inc. (NASDAQ: DRVN) Class Action Survives Motion to Dismiss: A securities fraud class action complaint against Driven Brands Holdings, Inc. (NASDAQ: DRVN) has survived defendants, attempts to dismiss the complaint. Grabar Law Office is now investigating claims on behalf of long-term Driven Brands shareholders.\u00a0The investigation concerns whether certain officers of the company have breached their fiduciary duties they owed to the company. If you have held Driven Brands (NASDAQ: DRVN) shares continuously since prior to October 27, 2021, you can seek corporate reforms, the return of funds back to the Company, and a court approved incentive award at no cost you. Visit https:\/\/grabarlaw.com\/the-latest\/driven-brands-shareholder-investigation\/ or contact Joshua H. Grabar at\u00a0jgrabar@grabarlaw.com or … <\/p>\n

Continue reading “Notice to Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Kyverna Therapeutics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Rocket Lab USA, Inc. (NASDAQ: RKLB): Grabar Law Office is Investigating Claims on Your Behalf”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-828487","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nNotice to Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Kyverna Therapeutics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Rocket Lab USA, Inc. (NASDAQ: RKLB): Grabar Law Office is Investigating Claims on Your Behalf - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-driven-brands-holdings-inc-nasdaq-drvn-kyverna-therapeutics-inc-nasdaq-kytx-mercury-systems-inc-nasdaq-mrcy-and-rocket-lab-usa-inc-nasdaq-rklb\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Notice to Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Kyverna Therapeutics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Rocket Lab USA, Inc. (NASDAQ: RKLB): Grabar Law Office is Investigating Claims on Your Behalf - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PHILADELPHIA, March 21, 2025 (GLOBE NEWSWIRE) — Driven Brands Holdings, Inc. (NASDAQ: DRVN) Class Action Survives Motion to Dismiss: A securities fraud class action complaint against Driven Brands Holdings, Inc. (NASDAQ: DRVN) has survived defendants, attempts to dismiss the complaint. Grabar Law Office is now investigating claims on behalf of long-term Driven Brands shareholders.\u00a0The investigation concerns whether certain officers of the company have breached their fiduciary duties they owed to the company. If you have held Driven Brands (NASDAQ: DRVN) shares continuously since prior to October 27, 2021, you can seek corporate reforms, the return of funds back to the Company, and a court approved incentive award at no cost you. Visit https:\/\/grabarlaw.com\/the-latest\/driven-brands-shareholder-investigation\/ or contact Joshua H. Grabar at\u00a0jgrabar@grabarlaw.com or … Continue reading "Notice to Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Kyverna Therapeutics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Rocket Lab USA, Inc. (NASDAQ: RKLB): Grabar Law Office is Investigating Claims on Your Behalf"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-driven-brands-holdings-inc-nasdaq-drvn-kyverna-therapeutics-inc-nasdaq-kytx-mercury-systems-inc-nasdaq-mrcy-and-rocket-lab-usa-inc-nasdaq-rklb\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-21T12:36:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5ODYzNCM2ODE3OTEyIzIyMDEyNzA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-shareholders-of-driven-brands-holdings-inc-nasdaq-drvn-kyverna-therapeutics-inc-nasdaq-kytx-mercury-systems-inc-nasdaq-mrcy-and-rocket-lab-usa-inc-nasdaq-rklb\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-shareholders-of-driven-brands-holdings-inc-nasdaq-drvn-kyverna-therapeutics-inc-nasdaq-kytx-mercury-systems-inc-nasdaq-mrcy-and-rocket-lab-usa-inc-nasdaq-rklb\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Notice to Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Kyverna Therapeutics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Rocket Lab USA, Inc. (NASDAQ: RKLB): Grabar Law Office is Investigating Claims on Your Behalf\",\"datePublished\":\"2025-03-21T12:36:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-shareholders-of-driven-brands-holdings-inc-nasdaq-drvn-kyverna-therapeutics-inc-nasdaq-kytx-mercury-systems-inc-nasdaq-mrcy-and-rocket-lab-usa-inc-nasdaq-rklb\\\/\"},\"wordCount\":1421,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-shareholders-of-driven-brands-holdings-inc-nasdaq-drvn-kyverna-therapeutics-inc-nasdaq-kytx-mercury-systems-inc-nasdaq-mrcy-and-rocket-lab-usa-inc-nasdaq-rklb\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5ODYzNCM2ODE3OTEyIzIyMDEyNzA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-shareholders-of-driven-brands-holdings-inc-nasdaq-drvn-kyverna-therapeutics-inc-nasdaq-kytx-mercury-systems-inc-nasdaq-mrcy-and-rocket-lab-usa-inc-nasdaq-rklb\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-shareholders-of-driven-brands-holdings-inc-nasdaq-drvn-kyverna-therapeutics-inc-nasdaq-kytx-mercury-systems-inc-nasdaq-mrcy-and-rocket-lab-usa-inc-nasdaq-rklb\\\/\",\"name\":\"Notice to Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Kyverna Therapeutics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Rocket Lab USA, Inc. (NASDAQ: RKLB): Grabar Law Office is Investigating Claims on Your Behalf - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-shareholders-of-driven-brands-holdings-inc-nasdaq-drvn-kyverna-therapeutics-inc-nasdaq-kytx-mercury-systems-inc-nasdaq-mrcy-and-rocket-lab-usa-inc-nasdaq-rklb\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-shareholders-of-driven-brands-holdings-inc-nasdaq-drvn-kyverna-therapeutics-inc-nasdaq-kytx-mercury-systems-inc-nasdaq-mrcy-and-rocket-lab-usa-inc-nasdaq-rklb\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5ODYzNCM2ODE3OTEyIzIyMDEyNzA=\",\"datePublished\":\"2025-03-21T12:36:41+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-shareholders-of-driven-brands-holdings-inc-nasdaq-drvn-kyverna-therapeutics-inc-nasdaq-kytx-mercury-systems-inc-nasdaq-mrcy-and-rocket-lab-usa-inc-nasdaq-rklb\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-shareholders-of-driven-brands-holdings-inc-nasdaq-drvn-kyverna-therapeutics-inc-nasdaq-kytx-mercury-systems-inc-nasdaq-mrcy-and-rocket-lab-usa-inc-nasdaq-rklb\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-shareholders-of-driven-brands-holdings-inc-nasdaq-drvn-kyverna-therapeutics-inc-nasdaq-kytx-mercury-systems-inc-nasdaq-mrcy-and-rocket-lab-usa-inc-nasdaq-rklb\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5ODYzNCM2ODE3OTEyIzIyMDEyNzA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5ODYzNCM2ODE3OTEyIzIyMDEyNzA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-shareholders-of-driven-brands-holdings-inc-nasdaq-drvn-kyverna-therapeutics-inc-nasdaq-kytx-mercury-systems-inc-nasdaq-mrcy-and-rocket-lab-usa-inc-nasdaq-rklb\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Notice to Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Kyverna Therapeutics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Rocket Lab USA, Inc. (NASDAQ: RKLB): Grabar Law Office is Investigating Claims on Your Behalf\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Notice to Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Kyverna Therapeutics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Rocket Lab USA, Inc. (NASDAQ: RKLB): Grabar Law Office is Investigating Claims on Your Behalf - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-driven-brands-holdings-inc-nasdaq-drvn-kyverna-therapeutics-inc-nasdaq-kytx-mercury-systems-inc-nasdaq-mrcy-and-rocket-lab-usa-inc-nasdaq-rklb\/","og_locale":"en_US","og_type":"article","og_title":"Notice to Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Kyverna Therapeutics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Rocket Lab USA, Inc. (NASDAQ: RKLB): Grabar Law Office is Investigating Claims on Your Behalf - Market Newsdesk","og_description":"PHILADELPHIA, March 21, 2025 (GLOBE NEWSWIRE) — Driven Brands Holdings, Inc. (NASDAQ: DRVN) Class Action Survives Motion to Dismiss: A securities fraud class action complaint against Driven Brands Holdings, Inc. (NASDAQ: DRVN) has survived defendants, attempts to dismiss the complaint. Grabar Law Office is now investigating claims on behalf of long-term Driven Brands shareholders.\u00a0The investigation concerns whether certain officers of the company have breached their fiduciary duties they owed to the company. If you have held Driven Brands (NASDAQ: DRVN) shares continuously since prior to October 27, 2021, you can seek corporate reforms, the return of funds back to the Company, and a court approved incentive award at no cost you. Visit https:\/\/grabarlaw.com\/the-latest\/driven-brands-shareholder-investigation\/ or contact Joshua H. Grabar at\u00a0jgrabar@grabarlaw.com or … Continue reading \"Notice to Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Kyverna Therapeutics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Rocket Lab USA, Inc. (NASDAQ: RKLB): Grabar Law Office is Investigating Claims on Your Behalf\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-driven-brands-holdings-inc-nasdaq-drvn-kyverna-therapeutics-inc-nasdaq-kytx-mercury-systems-inc-nasdaq-mrcy-and-rocket-lab-usa-inc-nasdaq-rklb\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-21T12:36:41+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5ODYzNCM2ODE3OTEyIzIyMDEyNzA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-driven-brands-holdings-inc-nasdaq-drvn-kyverna-therapeutics-inc-nasdaq-kytx-mercury-systems-inc-nasdaq-mrcy-and-rocket-lab-usa-inc-nasdaq-rklb\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-driven-brands-holdings-inc-nasdaq-drvn-kyverna-therapeutics-inc-nasdaq-kytx-mercury-systems-inc-nasdaq-mrcy-and-rocket-lab-usa-inc-nasdaq-rklb\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Notice to Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Kyverna Therapeutics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Rocket Lab USA, Inc. (NASDAQ: RKLB): Grabar Law Office is Investigating Claims on Your Behalf","datePublished":"2025-03-21T12:36:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-driven-brands-holdings-inc-nasdaq-drvn-kyverna-therapeutics-inc-nasdaq-kytx-mercury-systems-inc-nasdaq-mrcy-and-rocket-lab-usa-inc-nasdaq-rklb\/"},"wordCount":1421,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-driven-brands-holdings-inc-nasdaq-drvn-kyverna-therapeutics-inc-nasdaq-kytx-mercury-systems-inc-nasdaq-mrcy-and-rocket-lab-usa-inc-nasdaq-rklb\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5ODYzNCM2ODE3OTEyIzIyMDEyNzA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-driven-brands-holdings-inc-nasdaq-drvn-kyverna-therapeutics-inc-nasdaq-kytx-mercury-systems-inc-nasdaq-mrcy-and-rocket-lab-usa-inc-nasdaq-rklb\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-driven-brands-holdings-inc-nasdaq-drvn-kyverna-therapeutics-inc-nasdaq-kytx-mercury-systems-inc-nasdaq-mrcy-and-rocket-lab-usa-inc-nasdaq-rklb\/","name":"Notice to Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Kyverna Therapeutics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Rocket Lab USA, Inc. (NASDAQ: RKLB): Grabar Law Office is Investigating Claims on Your Behalf - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-driven-brands-holdings-inc-nasdaq-drvn-kyverna-therapeutics-inc-nasdaq-kytx-mercury-systems-inc-nasdaq-mrcy-and-rocket-lab-usa-inc-nasdaq-rklb\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-driven-brands-holdings-inc-nasdaq-drvn-kyverna-therapeutics-inc-nasdaq-kytx-mercury-systems-inc-nasdaq-mrcy-and-rocket-lab-usa-inc-nasdaq-rklb\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5ODYzNCM2ODE3OTEyIzIyMDEyNzA=","datePublished":"2025-03-21T12:36:41+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-driven-brands-holdings-inc-nasdaq-drvn-kyverna-therapeutics-inc-nasdaq-kytx-mercury-systems-inc-nasdaq-mrcy-and-rocket-lab-usa-inc-nasdaq-rklb\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-driven-brands-holdings-inc-nasdaq-drvn-kyverna-therapeutics-inc-nasdaq-kytx-mercury-systems-inc-nasdaq-mrcy-and-rocket-lab-usa-inc-nasdaq-rklb\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-driven-brands-holdings-inc-nasdaq-drvn-kyverna-therapeutics-inc-nasdaq-kytx-mercury-systems-inc-nasdaq-mrcy-and-rocket-lab-usa-inc-nasdaq-rklb\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5ODYzNCM2ODE3OTEyIzIyMDEyNzA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5ODYzNCM2ODE3OTEyIzIyMDEyNzA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-driven-brands-holdings-inc-nasdaq-drvn-kyverna-therapeutics-inc-nasdaq-kytx-mercury-systems-inc-nasdaq-mrcy-and-rocket-lab-usa-inc-nasdaq-rklb\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Notice to Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Kyverna Therapeutics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Rocket Lab USA, Inc. (NASDAQ: RKLB): Grabar Law Office is Investigating Claims on Your Behalf"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/828487","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=828487"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/828487\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=828487"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=828487"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=828487"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}